MDGL - Financial Reports List - Madrigal Pharmaceuticals, Inc. - IntrinsicAlpha

Madrigal Pharmaceuticals, Inc. MDGL

Healthcare - Biotechnology - NASDAQ - US

$ 300.27

-2.2 %

$ 6.63 B

Market Cap

-13.47

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	13318.18%	47.04%	42.82%
Annual Report	FY	10-K	2024-12-31	0.00%	-24.69%	-30.85%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-8.33%	-18.03%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-77.12%	-88.01%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-89.66%	-94.08%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-28.09%	-37.37%
Annual Report	FY	10-K	2023-12-31	0.00%	-24.83%	-29.61%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-19.40%	-22.54%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-19.98%	-23.02%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-35.09%	-36.36%

1